Team Hewins LLC bought a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,682 shares of the company’s stock, valued at approximately $381,000. Several other hedge […]